Zacks Investment Research
05 Aug 2026, 19:46 UTC · 1h ago
DaVita Stock Down in Pre-Market Despite Q2 Earnings Beat, Margins Down
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
Zacks Investment Research
05 Aug 2026, 19:46 UTC · 1h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
5 claims · each scored for market impact
DaVita Inc. shares fell nearly 7.1% in pre-market trading following its second quarter 2026 results. — A significant pre-market drop indicates strong negative investor reaction despite an earnings beat.
-0.60DaVita reported Q2 2026 adjusted EPS of $4.02, representing a 36.3% increase year-over-year and beating consensus estimates by 0.3%. — Strong earnings growth and a beat of analyst expectations are fundamentally positive.
+0.30Revenue per treatment (RPT) declined 0.4% sequentially due to a lower commercial mix from declining Affordable Care Act enrollment and lower phosphate binder contributions. — Sequential declines in a key pricing metric suggest pricing pressure or unfavorable payer mix shifts.
-0.30Continue reading
6 related stories
Top 3 movers · tap to explore
Q2 2026 revenues rose 5.2% year-over-year to $3.55 billion, slightly exceeding the Zacks Consensus Estimate. — Steady top-line growth and a consensus beat provide a positive fundamental signal.
+0.20DaVita's gross margin contracted by 38 basis points to 32.7% year-over-year. — Margin compression suggests rising costs or inefficiency in service delivery, weighing on profitability.
-0.20Which stocks this story touches
Despite beating EPS and revenue estimates, shares lost nearly 7.1% in pre-market trading due to sequential declines in revenue per treatment.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
GlobeNewsWire
56m ago
